MarketCap
Facebook
X
Telegram
Stoneridge Financial Ratios 2025-2008 | SRI
Brief overview of Stoneridge's valuation multiples
This overview follows the five latest available observations from 2016 through 2021.
The current valuation set is P/E 157.15x (median 13.69x), EV/EBITDA 2.3x (median 9.51x), P/S 0.19x (median 0.49x). The current ratio basket stands about 62.5% below the five-year comparison base. Earnings and risk trends should explain the discount.
The inverse P/E implies an earnings yield of 0.6%. This is not a dividend yield, but current earnings relative to market price.
Capital efficiency is characterized by ROE -57.2%, ROA -18.7%, ROCE -9.8%. The business is not generating positive returns on invested resources. Valuation should be read cautiously until earnings recover.
Price, earnings and growth produce a PEG of 0.16x. A value below one indicates moderate pricing relative to expected growth.
The cash conversion cycle is 88.3 days versus 81.6 days initially. Turnover changed little.
What the ratios show
Stoneridge's restrained price comes with modest current quality. Better efficiency is needed for revaluation.
Annual Financial Ratios Stoneridge
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.6 | -9.1 | -93.2 | -40.8 | 157.1 | -102.8 | 13.0 | 13.7 | 15.2 | 5.8 | 13.6 | -7.2 | 19.8 | 30.8 | 4.5 | 19.9 | -2.1 | - |
P/S |
0.2 | 0.2 | 0.5 | 0.6 | 0.7 | 1.3 | 0.9 | 0.9 | 0.8 | 0.6 | 0.5 | 0.5 | 0.3 | 0.2 | 0.3 | 0.4 | - | - |
EPS |
-3.7 | -0.6 | -0.2 | -0.5 | 0.1 | -0.3 | 2.2 | 1.9 | 1.6 | 2.8 | 0.8 | -1.8 | 0.6 | 0.2 | 2.0 | 0.5 | -1.4 | - |
EV (Enterprise Value) |
93.6 M | 78 M | 442 M | 518 M | 450 M | 743 M | 1.02 B | 932 M | 936 M | 604 M | 513 M | 582 M | 636 M | 519 M | 662 M | 157 M | -22.7 M | -92.7 M |
EBITDA per Share |
-0.22 | 1.23 | 1.69 | 1.34 | 1.82 | 0.93 | 3.7 | 3.4 | 3.05 | 2.44 | 1.85 | 2.07 | 2.81 | 2.43 | 1.54 | 1.79 | 0.06 | - |
EV/EBITDA |
-15.3 | 2.3 | 9.5 | 14.1 | 8.7 | 31.7 | 8.2 | 7.8 | 8.8 | 7.2 | 7.4 | 7.7 | 5.8 | 5.0 | 11.0 | 3.7 | -16.4 | - |
PEG |
0.16 | 6.85 | -15.85 | -13.83 | 11.88 | -237.21 | 0.91 | 0.76 | -0.36 | 0.02 | 0.09 | 0.02 | 0.11 | -0.34 | 0.01 | - | - | - |
P/B |
0.3 | 0.2 | 0.7 | 0.9 | 0.8 | 1.3 | 2.7 | 2.6 | 2.8 | 2.5 | 3.3 | 3.7 | 2.0 | 1.1 | 1.7 | 0.6 | - | - |
P/CF |
4.7 | 3.1 | 97.7 | 84.2 | -14.8 | 28.5 | -52.2 | 14.2 | 14.7 | 11.1 | 11.9 | -68.8 | 16.3 | 3.4 | -8.8 | 16.5 | 5.0 | - |
ROE % |
-57.20 | -6.74 | -1.80 | -5.00 | 1.15 | -2.68 | 20.80 | 19.01 | 18.51 | 43.44 | 24.46 | -51.62 | 10.16 | 3.58 | 37.67 | 13.27 | -42.71 | - |
ROA % |
-18.66 | -2.66 | -0.76 | -2.16 | 0.51 | -1.28 | 10.01 | 9.62 | 8.08 | 19.63 | 6.25 | -11.81 | 2.57 | 0.90 | 7.07 | 2.98 | - | - |
ROCE % |
-9.81 | -0.08 | 2.56 | 0.62 | 3.13 | -1.61 | 15.38 | 16.25 | 13.57 | 15.64 | 10.86 | 9.21 | 9.14 | 6.54 | 4.21 | 8.72 | -24.19 | - |
Current Ratio |
- | - | - | - | - | - | 2.4 | 2.2 | 2.2 | 2.1 | 2.1 | 2.0 | 2.2 | 2.0 | 1.5 | - | - | - |
DSO |
57.0 | 61.1 | 60.7 | 62.6 | 68.0 | 77.5 | 60.6 | 58.6 | 63.1 | 59.4 | 53.7 | 58.1 | 51.5 | 55.0 | 77.4 | 29.5 | - | - |
DIO |
75.1 | 86.1 | 80.2 | 73.2 | 69.1 | 68.0 | 55.0 | 47.5 | 46.5 | 43.8 | 47.6 | 55.4 | 57.7 | 49.1 | 71.2 | - | - | - |
DPO |
43.8 | 49.6 | 52.3 | 52.3 | 55.6 | 61.6 | 47.5 | 52.6 | 50.3 | 45.6 | 43.1 | 45.5 | 42.9 | 39.0 | 49.5 | - | - | - |
Operating Cycle |
132.2 | 147.2 | 140.9 | 135.8 | 137.2 | 145.5 | 115.6 | 106.1 | 109.6 | 103.2 | 101.3 | 113.4 | 109.2 | 104.1 | 148.6 | 29.5 | - | - |
Cash Conversion Cycle |
88.3 | 97.6 | 88.6 | 83.4 | 81.6 | 83.9 | 68.1 | 53.4 | 59.3 | 57.6 | 58.3 | 67.9 | 66.3 | 65.1 | 99.1 | 29.5 | - | - |
All numbers in USD currency
Quarterly Financial Ratios Stoneridge
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.19 | -1 | -0.34 | -0.34 | -0.26 | - | -0.26 | 0.1 | -0.22 | - | 0.08 | -0.11 | -0.27 | - | 0.03 | -0.27 | -0.28 | - | -0.38 | 0.73 | - | 0.13 | 0.25 | -0.81 | 0.13 | 0.15 | 0.24 | 1.43 | 0.34 | 0.42 | 0.47 | 0.53 | 0.47 | 0.67 | 0.29 | 0.32 | 0.33 | 1.74 | 0.37 | 0.42 | 0.26 | 0.22 | 0.26 | 0.26 | 0.09 | -0.99 | - | -0.81 | 0.05 | 0.01 | 0.19 | 0.22 | 0.15 | 0.1 | 0.02 | -0.13 | 0.22 | 1.58 | 0.19 | 0.14 | 0.12 |
EBITDA per Share |
0.16 | -0.12 | 0.22 | 0.18 | 0.15 | - | 0.33 | 0.43 | 0.32 | - | 0.55 | 0.46 | 0.16 | - | 0.52 | 0.1 | 0.21 | - | -0.03 | 1.3 | 0.39 | 0.21 | 0.66 | -0.71 | 0.43 | 0.04 | 0.63 | 2.04 | 0.66 | 0.44 | 0.89 | 0.92 | 0.87 | 0.47 | 0.72 | 0.81 | 0.77 | 0.37 | 0.95 | 0.84 | 0.47 | 0.3 | 0.87 | 0.64 | 0.3 | -0.81 | 1.22 | -0.37 | 0.54 | 0.34 | 0.78 | 0.76 | 0.65 | 0.31 | 0.58 | 0.4 | 0.79 | -0.29 | 0.49 | 0.52 | 0.48 |
ROE % |
-28.74 | -28.04 | -12.77 | -8.01 | -6.63 | -3.78 | -2.99 | -1.46 | -5.17 | -2.96 | -2.68 | -6.17 | -7.70 | -5.03 | -8.51 | -2.47 | 0.27 | 2.88 | 4.09 | 9.83 | -3.81 | -2.55 | -2.31 | -2.16 | 19.29 | 21.34 | 24.15 | 26.43 | 17.64 | 19.01 | 22.50 | 21.11 | 19.46 | 18.51 | 37.89 | 40.36 | 43.15 | 43.44 | 22.85 | 24.99 | 26.00 | 24.46 | -11.18 | -19.23 | -50.71 | -51.62 | -22.39 | -18.86 | 9.00 | 10.16 | 11.77 | 8.66 | 2.42 | 3.58 | 31.27 | 34.45 | 39.39 | 37.67 | 3.46 | 2.57 | 2.20 |
ROA % |
-9.44 | -9.49 | -5.11 | -3.21 | -2.65 | -1.56 | -1.24 | -0.61 | -2.12 | -1.22 | -1.10 | -2.60 | -3.82 | -2.72 | 0.40 | 0.28 | 0.30 | 1.48 | 2.06 | 4.79 | -1.82 | -1.28 | -1.16 | -1.13 | 8.97 | 10.01 | 11.47 | 12.74 | 8.84 | 9.62 | 10.85 | 9.92 | 8.83 | 8.08 | 16.96 | 18.13 | 19.45 | 19.63 | 9.04 | 8.46 | 7.44 | 6.25 | -2.08 | -4.13 | -11.54 | -11.81 | -5.12 | -4.23 | 2.24 | 2.57 | 2.98 | 2.19 | 0.61 | 0.90 | 6.01 | 6.59 | 7.67 | 7.09 | 0.65 | 0.48 | 0.41 |
ROCE % |
-4.31 | -4.61 | -1.90 | -0.47 | 0.17 | 0.84 | 3.03 | 4.40 | 2.84 | 2.77 | 4.06 | -0.31 | -2.38 | -1.52 | -3.46 | 0.90 | 3.51 | 4.14 | 5.33 | 9.34 | -1.95 | -1.56 | -2.52 | -2.52 | 13.93 | 15.64 | 18.48 | 20.85 | 14.70 | 16.25 | 16.31 | 15.01 | 14.07 | 13.57 | 14.23 | 15.48 | 16.86 | 16.44 | 16.08 | 15.37 | 13.34 | 11.45 | -0.88 | 0.81 | -11.32 | -10.09 | 1.24 | -0.95 | 11.10 | 10.73 | 10.50 | 8.99 | 6.42 | 7.27 | 3.13 | 3.25 | 4.74 | 3.47 | 1.80 | 1.90 | 1.72 |
DSO |
69.4 | 83.2 | 68.6 | 64.0 | 61.7 | - | 69.7 | 65.2 | 64.3 | - | 69.4 | 61.7 | 63.1 | - | 33.6 | 32.2 | 63.2 | - | 72.9 | 72.2 | 67.4 | 65.8 | 71.0 | 125.3 | 68.7 | 66.4 | 62.2 | 56.9 | 58.0 | 60.2 | 60.8 | 57.5 | 56.9 | 62.7 | 63.8 | 62.2 | 57.1 | 59.9 | 59.4 | 55.3 | 58.4 | 56.0 | 53.5 | 52.4 | 56.0 | 57.5 | 56.3 | 59.2 | 58.7 | 55.2 | 57.9 | 63.5 | 53.3 | 58.0 | 58.9 | 55.1 | 52.9 | 79.6 | 75.6 | 77.8 | - |
DIO |
70.8 | 93.0 | 79.0 | 75.5 | 80.6 | - | 95.7 | 89.3 | 87.9 | - | 88.1 | 76.1 | 73.8 | - | 38.8 | 37.1 | 72.8 | - | 75.0 | 64.6 | 57.5 | - | 63.7 | 95.8 | 61.0 | - | 56.3 | 51.5 | 50.0 | - | 49.7 | 47.2 | 44.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
66.8 | 74.4 | 56.5 | 51.7 | 48.0 | - | 55.6 | 54.1 | 52.9 | - | 65.7 | 59.4 | 55.7 | - | 27.4 | 25.7 | 50.9 | - | 62.5 | 57.1 | 54.1 | - | 60.5 | 91.0 | 55.3 | - | 48.6 | 44.5 | 48.9 | - | 55.1 | 52.4 | 48.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | 147.6 | 139.5 | 142.3 | - | 165.4 | 154.4 | 152.2 | - | 157.5 | 137.8 | 136.9 | - | 72.3 | 69.3 | 136.0 | - | 147.9 | 136.8 | 124.9 | 65.8 | 134.7 | 221.1 | 129.7 | 66.4 | 118.4 | 108.4 | 108.1 | 60.2 | 110.5 | 104.8 | 101.0 | 62.7 | 63.8 | 62.2 | 57.1 | 59.9 | 59.4 | 55.3 | 58.4 | 56.0 | 53.5 | 52.4 | 56.0 | 57.5 | 56.3 | 59.2 | 58.7 | 55.2 | 57.9 | 63.5 | 53.3 | 58.0 | 58.9 | 55.1 | 52.9 | 79.6 | 75.6 | 77.8 | - |
Cash Conversion Cycle |
- | - | 91.0 | 87.8 | 94.3 | - | 109.9 | 100.3 | 99.3 | - | 91.8 | 78.4 | 81.3 | - | 45.0 | 43.6 | 85.1 | - | 85.4 | 79.7 | 70.8 | 65.8 | 74.1 | 130.1 | 74.3 | 66.4 | 69.8 | 63.9 | 59.2 | 60.2 | 55.4 | 52.4 | 52.6 | 62.7 | 63.8 | 62.2 | 57.1 | 59.9 | 59.4 | 55.3 | 58.4 | 56.0 | 53.5 | 52.4 | 56.0 | 57.5 | 56.3 | 59.2 | 58.7 | 55.2 | 57.9 | 63.5 | 53.3 | 58.0 | 58.9 | 55.1 | 52.9 | 79.6 | 75.6 | 77.8 | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Stoneridge, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
USA
Russia
China
Schweden
Israel
Canada
Irlanda
Britain
